WeVote
Log In

Bill

Bill

SB 339

Medi-Cal: laboratory rates.

2025-2026 Regular Session Introduced by Christopher Cabaldon

SB 339 adjusts Medi-Cal reimbursement rates for clinical laboratory services, balancing lab provider sustainability with state budget management and patient access.

May 23 hearing: Held in committee and under submission.
#medi-cal #laboratoryrates
0
WeVote Research Nonpartisan
Bill Summary · SB 339

Legislative bill overview

SB 339 modifies Medi-Cal reimbursement rates for laboratory services provided by clinical laboratories. The bill aims to adjust how the state pays for lab tests under the Medi-Cal program, potentially affecting rates paid to laboratories that serve Medi-Cal beneficiaries.

Why is this important

Laboratory services are essential healthcare components, and reimbursement rates directly impact whether labs can afford to serve low-income Medi-Cal patients. Changes to these rates affect both the financial viability of lab providers and the state budget, as Medi-Cal is one of California's largest spending programs.

Potential points of contention

  • Rate adequacy debate: Laboratories may argue proposed rates are insufficient to cover operational costs, while state officials may prioritize budget constraints and fiscal responsibility
  • Access concerns: If rates are cut too aggressively, some labs may reduce Medi-Cal services or exit the program entirely, potentially limiting patient access in rural or underserved areas
  • Provider vs. payer interests: Clinical laboratory associations likely oppose rate reductions, while the state seeks to control healthcare spending

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.